[Respiratory syncytial virus (RSV) as a common cause of respiratory illness in children younger than 5 years].
Poehling
Katherine A
KA
Hickson
Gerald B
GB
D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D061067:Antibodies, Monoclonal, Humanized; D000914:Antibodies, Viral / Q000276:immunology / Q000627:therapeutic use*; D006801:Humans; D016756:Immunoglobulins, Intravenous / Q000627:therapeutic use*; D000069455:Palivizumab; D017410:Practice Guidelines as Topic; D018357:Respiratory Syncytial Virus Infections / Q000188:drug therapy* / Q000276:immunology; D012136:Respiratory Syncytial Viruses / Q000276:immunology; D011795:Surveys and Questionnaires
D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000914:Antibodies, Viral; D016756:Immunoglobulins, Intravenous; D000069455:Palivizumab